Assessment of the Efficacy of Andrographis Paniculata in Subjects With Mild to Moderate Osteoarthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a 12 weeks randomized, double-blind, placebo-controlled clinical study to assess the effect of Andrographis Paniculata at low dose of 300 mg/day and high dose of 600 mg/day in the study population in the age range of 40-70 years and suffering from mild-moderate OA.
Epistemonikos ID: 3ecb69d4f4819fb40e94f7680008a4a174906c66
First added on: May 21, 2024